Pharmafile Logo

The Opportunity for Women’s Health in Emerging Markets

June 3, 2016 | emerging markets 

Published in eyeforpharma April 2016 by Rachel Howard

In our latest article for eyeforpharma, Associate Director Rachel Howard looks at what we mean by “women’s health” and outlines some of the considerations for pharma companies who want to maximize their opportunity in emerging markets. Gender roles, societal norms, culture, demographics, lifestyle and religion all have an impact on women’s health, so Howard advises that pharma start by building a full understanding of women in the markets in which they hope to successfully operate.

http://www.researchpartnership.com/news/2016/04/article-the-opportunity-for-women%E2%80%99s-health-i…

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market

From chaos to calm: how to make sense of social media

What do you know about chaos theory?

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

Infographic: HCV LATAM

An introduction to the HCV LATAM patient.

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard